Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV envelope glycoprotein complex (Env), composed of gp120 and gp41, is essential for viral entry into host cells. Gp120 binds to CD4 and coreceptors (CCR5 or CXCR4) on the host cell, triggering conformational changes in gp41. Gp41 then mediates the fusion of the viral and cellular membranes, allowing the viral capsid to enter the host cell. This process is a key target for antiviral drugs.
Inhibition of gp41 six-helix bundle formation, blocking membrane fusion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV Envelope Glycoprotein Complex (Env).